Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiora Pharmaceuticals

3.05
-0.0600-1.93%
Post-market: 3.100.0500+1.64%16:26 EDT
Volume:24.73K
Turnover:76.38K
Market Cap:9.28M
PE:-1.06
High:3.13
Open:3.12
Low:3.04
Close:3.11
Loading ...
Dec 22, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 21, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 13, 2022

Major Issues Report

8-K - Current report
Oct 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 26, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Major Issues Report

8-K - Current report
Sep 16, 2022

Major Issues Report

8-K - Current report
Aug 25, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 28, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 26, 2022

Major Issues Report

8-K - Current report
Jul 21, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 21, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 19, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 19, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 14, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses